Industry Overview
The Problem
- Though the ability of preventing Ischemic Stroke is real, current modalities and procedures do not allow for intervention prior to the occurrence
- A patient is only sent for arterial evaluation if they are presenting symptoms of stroke, and since stroke is frequently asymptomatic there typically is no further testing
- There is a high cost associated with current screening modalities available (Duplex Doppler Ultrasound, MRA, CTA, and Digital Subtraction) which compound this problem

Stroke/Carotid Artery Disease Statistics

Leading Cause of Disability (Globally)

3rd Leading Cause of Death (USA)

Asymptomatic

795,000 Stroke Incidents Yearly (USA)
Ischemic
87%
Hemorrhagic
13%

3rd Leading Cause of Death (USA)
Permanent Impairment
50%
Recover
38%
Fatal
12%

Cost
2010
$71.6 Billion
2030
Cost Estimated to Triple


Previous
Next
